Hypothyroidism and women's health

Area of Science:

• Endocrinology
• Women's Health
• Reproductive Medicine

Background:

• Hypothyroidism affects 4-10% of women, increasing with age, presenting with nonspecific symptoms like fatigue and weight gain.
• Hashimoto's thyroiditis is the most common cause, often resulting in a firm, irregular thyroid gland.
• Screening is recommended by major medical associations due to links between even subclinical hypothyroidism and adverse pregnancy outcomes.

Purpose of the Study:

• To highlight the prevalence and subtle symptoms of hypothyroidism in women.
• To emphasize the importance of laboratory diagnosis over symptomatic presentation.
• To advocate for universal screening in women planning conception or during pregnancy.

Main Methods:

• Diagnosis relies on laboratory tests, primarily TSH determination, with third-generation assays being most accurate.
• Physical examination may reveal thyroid irregularities in cases of Hashimoto's thyroiditis.
• Monitoring TSH levels is essential for dose titration of levothyroxine treatment.

Main Results:

• Subtle hypothyroidism is linked to increased miscarriage, late fetal demise, and lower offspring IQ.
• Most patients with elevated TSH benefit from treatment, despite ongoing debate.
• Levothyroxine is the standard lifelong treatment for hypothyroidism, with brand consistency advised due to bioavailability variations.

Conclusions:

• Hypothyroidism diagnosis requires laboratory confirmation; symptoms are often nonspecific.
• Screening all women intending conception or pregnancy is strongly suggested.
• Prompt treatment with levothyroxine, guided by TSH monitoring, is vital for positive maternal and fetal outcomes.